40 Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-old – ET HealthWorld by Shafiq 2 weeks ago2 weeks ago
00 bharat biotech: DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age group | India News – Times of India by Shafiq 3 weeks ago3 weeks ago
